Physicians and Providers

Health Advisories

Mumps Health Advisory 08/08/17

Infectious Diseases

The Screening Tool for Infectious Diseases aids healthcare providers in evaluating patients for potential infectious diseases of interest and provides them with appropriate steps to control transmission in healthcare settings.

 


Zika in Texas

For Health Care Providers

 

                    

 

 

 

800-CDC-INFO
(800-232-4636)
TTY 888-232-6348

 

Monday - Friday
8:00 a.m. - 8:00 p.m. EST

(regular hours, for all inquiries)
8:00 p.m. – 11:00 p.m. EST
(extended hours, for Zika inquiries only)

Saturday and Sunday
9:00 a.m. - 5:00 p.m. EST

(for Zika inquiries only)

In English or Spanish

 


Cyclospora in Texas

 


Ebola (Ebola Virus Disease)

From the CDC:

Early recognition is critical for infection control. Health care providers should be alert for and evaluate any patients suspected of having Ebola Virus Disease (EVD).

 

Links

CDC-INFO: (800) CDC-INFO, or (800) 232-4636

 

Person Under Investigation (PUI)

A person who has both consistent symptoms and risk factors as follows:

  1. Clinical criteria, which includes fever (subjective or ≥ 100.4ºF or 38.0ºC), and additional symptoms such as severe headache, muscle pain, vomiting, diarrhea, abdominal pain, or unexplained hemorrhage; AND
  2. Epidemiologic risk factors within the past 21 days before the onset of symptoms, such as contact with blood or other body fluids or human remains of a patient known to have or suspected to have EVD; residence in—or travel to—an area where EVD transmission is active; or direct handling of bats or non-human primates from disease-endemic areas.

 

Probable Case

A PUI whose epidemiologic risk factors include high or low risk exposure(s) (see below)

 

Confirmed Case

A case with laboratory-confirmed diagnostic evidence of Ebola virus infection

 

Exposure Risk Levels

Levels of exposure risk are defined as follows:

  • High risk exposures
    A high risk exposure includes any of the following:
    • Percutaneous (e.g., needle stick) or mucous membrane exposure to blood or body fluids of EVD patient
    • Direct skin contact with, or exposure to blood or body fluids of, an EVD patient without appropriate personal protective equipment (PPE)
    • Processing blood or body fluids of a confirmed EVD patient without appropriate PPE or standard biosafety precautions
    • Direct contact with a dead body without appropriate PPE in a country where an EVD outbreak is occurring*
       
  • Low risk exposures
    A low risk exposure includes any of the following:
    • Household contact with an EVD patient
    • Other close contact with EVD patients in health care facilities or community settings.
      Close contact is defined as
      • being within approximately 3 feet (1 meter) of an EVD patient or within the patient’s room or care area for a prolonged period of time (e.g., health care personnel, household members) while not wearing recommended personal protective equipment (i.e., standard, droplet, and contact precautions; see Infection Prevention and Control Recommendations)
      • having direct brief contact (e.g., shaking hands) with an EVD patient while not wearing recommended personal protective equipment.
    • Brief interactions, such as walking by a person or moving through a hospital, do not constitute close contact
       
  • No known exposure
    Having been in a country in which an EVD outbreak occurred within the past 21 days and having had no high or low risk exposures

 

Personal Protective Equipment

(PPE) Demonstration

 


TB Information

9/18/14 TB Exposure in a Healthcare Facility

The City of El Paso Department of Public Health (DPH) has determined that more than 700 infants and more than 40 employees have been exposed to Tuberculosis (TB) by a healthcare worker who has been diagnosed with Active Tuberculosis. Exposure occurred between September 2013 and August 2014 at Providence Memorial Hospital (PMH) in the post-partum and newborn nursery area.

DPH and PMH are working closely with state health officials and the Centers for Disease Control and Prevention (CDC) in this exposure incident’s investigation and management. The worker is currently receiving treatment and is not currently working at PMH. Patients and staff who may have been exposed are being notified via telephone and certified letter and are being instructed to call 2-1-1 or 1-877-541-7905 to have their questions and concerns addressed. The public is also encouraged to visit www.EPHealth.com for general information regarding TB.

On Thursday, September 18, 2014, DPH and PMH sent joint notification letters to the specific families of the patients who may have had close contact with the healthcare worker during the aforementioned time frame.

Parents of infants born at PMH between Sept 2013 and Aug 2014 are being contacted by DPH to initiate post-exposure screening including Tuberculin Skin Testing and chest x-rays. Window prophylaxis is recommended for children aged six months and younger. Diagnostic and treatment services provided by DPH or PMH will be at no cost to those who were exposed.

This alert is to inform healthcare providers of the hospital-based exposure as parents may choose to contact their child’s physician rather than presenting at the DPH for follow-up. Coordinated communication and care between private physicians and DPH will be key for optimal community health. As necessary, DPH will be requiring submission of state mandated reporting forms.

Please call the DPH at 915-212-6609 if you need to speak to a TB clinician. Patients who receive a letter must make an appointment for any infant patient who was exposed. Please have the parent call 2-1-1 or 1-877-541-7905 Monday – Friday between 8:00 a.m. and 5:00 p.m.

 

Additional Information

 

General Information Regarding Tuberculosis